Annual CFI
-$225.68 M
-$225.68 M-100.00%
December 1, 2024
Summary
- As of March 12, 2025, SLNO annual cash flow from investing activities is -$225.68 million, with the most recent change of -$225.68 million (-100.00%) on December 1, 2024.
- During the last 3 years, SLNO annual CFI has fallen by -$225.66 million (-1025727.27%).
- SLNO annual CFI is now -42842.80% below its all-time high of $528.00 thousand, reached on December 31, 2019.
Performance
SLNO Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$6.44 M
+$2.40 M+59.48%
December 1, 2024
Summary
- As of March 12, 2025, SLNO quarterly cash flow from investing activities is $6.44 million, with the most recent change of +$2.40 million (+59.48%) on December 1, 2024.
- Over the past year, SLNO quarterly CFI has stayed the same.
- SLNO quarterly CFI is now at all-time high.
Performance
SLNO Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
-$225.68 M
+$6.44 M+2.78%
December 1, 2024
Summary
- As of March 12, 2025, SLNO TTM cash flow from investing activities is -$225.68 million, with the most recent change of +$6.44 million (+2.78%) on December 1, 2024.
- Over the past year, SLNO TTM CFI has stayed the same.
- SLNO TTM CFI is now -41585.66% below its all-time high of $544.00 thousand, reached on June 30, 2020.
Performance
SLNO TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
SLNO Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -100.0% | 0.0% | 0.0% |
| 3 y3 years | -10000.0% | 0.0% | 0.0% |
| 5 y5 years | -10000.0% | 0.0% | 0.0% |
SLNO Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | <-9999.0% | at low | at high | +105.3% | <-9999.0% | +4.4% |
| 5 y | 5-year | <-9999.0% | at low | at high | +105.3% | <-9999.0% | +4.4% |
| alltime | all time | <-9999.0% | at low | at high | +105.3% | <-9999.0% | +4.4% |
Soleno Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | -$225.68 M(<-9900.0%) | $6.44 M(+59.5%) | -$225.68 M(-2.8%) |
| Sep 2024 | - | $4.04 M(-103.3%) | -$232.13 M(-1.7%) |
| Jun 2024 | - | -$120.92 M(+4.9%) | -$236.16 M(+104.9%) |
| Mar 2024 | - | -$115.24 M(<-9900.0%) | -$115.24 M(<-9900.0%) |
| Dec 2023 | $0.00(-100.0%) | $0.00(0.0%) | $0.00(-100.0%) |
| Sep 2023 | - | $0.00(0.0%) | -$6000.00(0.0%) |
| Jun 2023 | - | $0.00(0.0%) | -$6000.00(-53.8%) |
| Mar 2023 | - | $0.00(-100.0%) | -$13.00 K(0.0%) |
| Dec 2022 | -$13.00 K(-40.9%) | -$6000.00(<-9900.0%) | -$13.00 K(-35.0%) |
| Sep 2022 | - | $0.00(-100.0%) | -$20.00 K(-20.0%) |
| Jun 2022 | - | -$7000.00(<-9900.0%) | -$25.00 K(+38.9%) |
| Mar 2022 | - | $0.00(-100.0%) | -$18.00 K(-18.2%) |
| Dec 2021 | -$22.00 K(+214.3%) | -$13.00 K(+160.0%) | -$22.00 K(+69.2%) |
| Sep 2021 | - | -$5000.00(<-9900.0%) | -$13.00 K(+18.2%) |
| Jun 2021 | - | $0.00(-100.0%) | -$11.00 K(0.0%) |
| Mar 2021 | - | -$4000.00(0.0%) | -$11.00 K(+57.1%) |
| Dec 2020 | -$7000.00(-101.3%) | -$4000.00(+33.3%) | -$7000.00(-107.0%) |
| Sep 2020 | - | -$3000.00(<-9900.0%) | $100.00 K(-81.6%) |
| Jun 2020 | - | $0.00(0.0%) | $544.00 K(+1.1%) |
| Mar 2020 | - | $0.00(-100.0%) | $538.00 K(+1.9%) |
| Dec 2019 | $528.00 K(-393.3%) | $103.00 K(-76.6%) | $528.00 K(+110.4%) |
| Sep 2019 | - | $441.00 K(-7450.0%) | $251.00 K(-228.7%) |
| Jun 2019 | - | -$6000.00(-40.0%) | -$195.00 K(+2.6%) |
| Mar 2019 | - | -$10.00 K(-94.3%) | -$190.00 K(+5.6%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2018 | -$180.00 K(-216.9%) | -$174.00 K(+3380.0%) | -$180.00 K(-2100.0%) |
| Sep 2018 | - | -$5000.00(+400.0%) | $9000.00(-94.3%) |
| Jun 2018 | - | -$1000.00(<-9900.0%) | $157.00 K(-0.6%) |
| Mar 2018 | - | $0.00(-100.0%) | $158.00 K(+2.6%) |
| Dec 2017 | $154.00 K(-497.9%) | $15.00 K(-89.5%) | $154.00 K(+10.6%) |
| Sep 2017 | - | $143.00 K(>+9900.0%) | $139.30 K(-3864.9%) |
| Jun 2017 | - | $0.00(-100.0%) | -$3700.00(-84.4%) |
| Mar 2017 | - | -$4000.00(-1433.3%) | -$23.70 K(-38.8%) |
| Dec 2016 | -$38.70 K(-97.1%) | $300.00(>+9900.0%) | -$38.70 K(-45.3%) |
| Sep 2016 | - | $0.00(-100.0%) | -$70.80 K(-94.7%) |
| Jun 2016 | - | -$20.00 K(+5.3%) | -$1.33 M(-0.7%) |
| Mar 2016 | - | -$19.00 K(-40.3%) | -$1.34 M(+1.4%) |
| Dec 2015 | -$1.32 M(+4202.3%) | -$31.80 K(-97.5%) | -$1.32 M(+0.1%) |
| Sep 2015 | - | -$1.26 M(+4093.3%) | -$1.32 M(+2004.8%) |
| Jun 2015 | - | -$30.00 K(+2900.0%) | -$62.70 K(+75.6%) |
| Mar 2015 | - | -$1000.00(-96.7%) | -$35.70 K(+16.3%) |
| Dec 2014 | -$30.70 K(+2261.5%) | -$30.70 K(+2970.0%) | -$30.70 K(>+9900.0%) |
| Sep 2014 | - | -$1000.00(-66.7%) | -$300.00(0.0%) |
| Jun 2014 | - | -$3000.00(-175.0%) | -$300.00(-107.5%) |
| Mar 2014 | - | $4000.00(-1433.3%) | $4000.00(-407.7%) |
| Dec 2013 | -$1300.00(-48.0%) | -$300.00(-70.0%) | -$1300.00(+30.0%) |
| Sep 2013 | - | -$1000.00(-176.9%) | -$1000.00(<-9900.0%) |
| Jun 2013 | - | $1300.00(-200.0%) | $0.00(-100.0%) |
| Mar 2013 | - | -$1300.00 | -$1300.00 |
| Dec 2012 | -$2500.00 | - | - |
FAQ
- What is Soleno Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Soleno Therapeutics?
- What is Soleno Therapeutics annual CFI year-on-year change?
- What is Soleno Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Soleno Therapeutics?
- What is Soleno Therapeutics quarterly CFI year-on-year change?
- What is Soleno Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Soleno Therapeutics?
- What is Soleno Therapeutics TTM CFI year-on-year change?
What is Soleno Therapeutics annual cash flow from investing activities?
The current annual CFI of SLNO is -$225.68 M
What is the all time high annual CFI for Soleno Therapeutics?
Soleno Therapeutics all-time high annual cash flow from investing activities is $528.00 K
What is Soleno Therapeutics annual CFI year-on-year change?
Over the past year, SLNO annual cash flow from investing activities has changed by -$225.68 M (-100.00%)
What is Soleno Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of SLNO is $6.44 M
What is the all time high quarterly CFI for Soleno Therapeutics?
Soleno Therapeutics all-time high quarterly cash flow from investing activities is $6.44 M
What is Soleno Therapeutics quarterly CFI year-on-year change?
Over the past year, SLNO quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Soleno Therapeutics TTM cash flow from investing activities?
The current TTM CFI of SLNO is -$225.68 M
What is the all time high TTM CFI for Soleno Therapeutics?
Soleno Therapeutics all-time high TTM cash flow from investing activities is $544.00 K
What is Soleno Therapeutics TTM CFI year-on-year change?
Over the past year, SLNO TTM cash flow from investing activities has changed by $0.00 (0.00%)